Tenor Capital Management’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Tenor Capital Management’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-33,333	Closed	-$637	–	498
2023 Q1	$637	Hold	33,333	–	–	﹤0.01%	497
2022 Q4	$4.96K	Hold	33,333	–	–	﹤0.01%	488
2022 Q3	$6K	Hold	33,333	–	–	﹤0.01%	659
2022 Q2	$4K	Hold	33,333	–	–	﹤0.01%	818
2022 Q1	$26K	Hold	33,333	–	–	﹤0.01%	686
2021 Q4	$20K	Hold	33,333	–	–	﹤0.01%	777
2021 Q3	$32K	Hold	33,333	–	–	﹤0.01%	677
2021 Q2	$49K	Buy	+33,333	New	+$29.1K	﹤0.01%	683

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Tenor Capital Management's PEARW Position: Q2 2023 in Review

Tenor Capital Management sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 33,333 shares — an estimated $637 sold.

Tenor Capital Management first reported a position in PEARW in Q2 2021 and held it in 8 quarters. The position peaked at $49K in Q2 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Tenor Capital Management reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Tenor Capital Management sold 33,333 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $637.
Tenor Capital Management first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 8 quarters.
Tenor Capital Management's Pear Therapeutics, Inc. Warrant position peaked at $49K in Q2 2021.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Tenor Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.